Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis

被引：0
|
作者：
Mathilde Roumier
Romain Paule
Alexandre Vallée
Julien Rohmer
Marie Ballester
Anne-Laure Brun
Charles Cerf
Marie-Laure Chabi
Thierry Chinet
Marie-Alice Colombier
Eric Farfour
Erwan Fourn
Guillaume Géri
David Khau
Ibrahim Marroun
Matthieu Ponsoye
Antoine Roux
Hélène Salvator
Yoland Schoindre
Anne-Gaëlle Si Larbi
Colas Tchérakian
Marc Vasse
Anne Verrat
Benjamin Zuber
Louis-Jean Couderc
Jean-Emmanuel Kahn
Matthieu Groh
Félix Ackermann
机构：
[1] Foch Hospital,Department of Internal Medicine
[2] Paris-Descartes University,Diagnosis and Therapeutic Center, Hypertension and Cardiovascular Prevention Unit, AP
[3] Foch Hospital,HP, Hôtel
[4] Foch Hospital,Dieu Hospital
[5] Foch Hospital,Emergency Department
[6] Ambroise Paré Hospital,Department of Radiology
[7] AP-HP,Department of Anesthesiology and Intensive Care
[8] Université Paris-Saclay,Department of Respiratory Medicine
[9] Foch Hospital,Simone Veil Medical Faculty
[10] Ambroise Paré Hospital,Department of Clinical Biology & INSERM UMRS
[11] AP-HP,1176
[12] INSERM UMR 1018,Medical Intensive Care Unit
[13] Foch Hospital,Department of Respiratory Medicine
[14] Ambroise Paré Hospital,Department of Internal Medicine
[15] AP-HP,undefined
来源：
Journal of Clinical Immunology | 2021年 / 41卷
关键词：
COVID-19; tocilizumab; interleukin-6; cytokine storm; intensive care unit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：303 / 314
页数：11
相关论文
共 50 条
  • [1] Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis
    Roumier, Mathilde
    Paule, Romain
    Vallee, Alexandre
    Rohmer, Julien
    Ballester, Marie
    Brun, Anne-Laure
    Cerf, Charles
    Chabi, Marie-Laure
    Chinet, Thierry
    Colombier, Marie-Alice
    Farfour, Eric
    Fourn, Erwan
    Geri, Guillaume
    Khau, David
    Marroun, Ibrahim
    Ponsoye, Matthieu
    Roux, Antoine
    Salvator, Helene
    Schoindre, Yoland
    Si Larbi, Anne-Gaelle
    Tcherakian, Colas
    Vasse, Marc
    Verrat, Anne
    Zuber, Benjamin
    Couderc, Louis-Jean
    Kahn, Jean-Emmanuel
    Groh, Matthieu
    Ackermann, Felix
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (02) : 303 - 314
  • [2] Tocilizumab for severe COVID-19 pneumonia
    Mourad, Jean-Jacques
    Azria, Philippe
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (11): : E659 - E659
  • [3] Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
    Rosas, I. O.
    Brau, N.
    Waters, M.
    Go, R. C.
    Hunter, B. D.
    Bhagani, S.
    Skiest, D.
    Aziz, M. S.
    Cooper, N.
    Douglas, I. S.
    Savic, S.
    Youngstein, T.
    Del Sorbo, L.
    Gracian, A. Cubillo
    De la Zerda, D. J.
    Ustianowski, A.
    Bao, M.
    Dimonaco, S.
    Graham, E.
    Matharu, B.
    Spotswood, H.
    Tsai, L.
    Malhotra, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1503 - 1516
  • [4] Tocilizumab for Severe and Critical COVID-19 Pneumonia in Queens, NYC
    Salama, Carlos
    Kaplan-Lewis, Emma
    Durrance, Richard
    Wong, Linda
    Arumugam, Vasanthi
    Fabbri, Marilyn
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2021, 29 (04) : E215 - E220
  • [5] EFFECTS OF CORTICOSTEROID TREATMENT FOR NON-SEVERE COVID-19 PNEUMONIA: A PROPENSITY SCORE-BASED ANALYSIS
    Yuan, Mingli
    Xu, Xiaoxiao
    Xia, Dongping
    Tao, Zhaowu
    Yin, Wen
    Tan, Weijun
    Hu, Yi
    Song, Cheng
    [J]. SHOCK, 2020, 54 (05): : 638 - 643
  • [6] Tocilizumab in severe COVID-19
    Liberato, Nicola Lucia
    De Monte, Andrea
    Caravella, Giuseppe
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (06) : 1457 - 1458
  • [7] Tocilizumab treatment in COVID-19: A prognostic study using propensity score matching
    Guclu, Ozge Aydin
    Onal, Ugur
    Akalin, Halis
    Ozturk, Nilufer Aylin Acet
    Belik, Hazel Ozturk
    Demirdogen, Ezgi
    Dilektasli, Asli Gorek
    Kazak, Esra
    Ocakoglu, Gokhan
    Saglik, Imran
    Coskun, Funda
    Ediger, Dane
    Heper, Yasemin
    Ursavas, Ahmet
    Yilmaz, Emel
    Uzaslan, Esra
    Karadag, Mehmet
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (11): : 1197 - 1206
  • [8] Tocilizumab versus anakinra in COVID-19: results from propensity score matching
    Arcani, Robin
    Correard, Florian
    Suchon, Pierre
    Kaplanski, Gilles
    Jean, Rodolphe
    Cauchois, Raphael
    Leprince, Marine
    Arcani, Vincent
    Seguier, Julie
    De Sainte Marie, Benjamin
    Andre, Baptiste
    Koubi, Marie
    Rossi, Pascal
    Gayet, Stephane
    Gobin, Nirvina
    Garrido, Victoria
    Weiland, Joris
    Jouve, Elisabeth
    Couderc, Anne-Laure
    Villani, Patrick
    Daumas, Aurelie
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] Tocilizumab in COVID-19 interstitial pneumonia
    Pomponio, G.
    Ferrarini, A.
    Bonifazi, M.
    Moretti, M.
    Salvi, A.
    Giacometti, A.
    Tavio, M.
    Titolo, G.
    Morbidoni, L.
    Frausini, G.
    Onesta, M.
    Amico, D.
    Rocchi, M. L. B.
    Menzo, S.
    Zuccatosta, L.
    Mei, F.
    Menditto, V.
    Svegliati, S.
    Donati, A.
    D'Errico, M. M.
    Pavani, M.
    Gabrielli, A.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2021, 289 (05) : 738 - 746
  • [10] Effect of Tocilizumab Therapy on Patient Outcome in Severe COVID-19 Pneumonia
    Yildiz, Mehmet
    Sultanova, Fidan
    Ozger, Hasan Selcuk
    Buyukkoruk, Merve
    Erbay, Kubra
    Gaygisiz, Ummugulsum
    Tufan, Abdurrahman
    Gulbahar, Ozlem
    Ozcan, Fatma Zehra
    Kuscu, Nazli Elif
    Gazioglu, Deniz
    Cifci, Beyza
    Sen, Fulya
    Senol, Esin
    Hizel, Kenan
    Tunccan, Ozlem Guzel
    Yildiz, Pinar Aysert
    Yildiz, Yesim
    Dizbay, Murat
    [J]. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2021, 3 (02): : 55 - 63
12345